Assignee

VTV THERAPEUTICS LLC

US47 patents

Top patents by PatentIndex Score

US10287284B2May 14, 2019

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

VTV THERAPEUTICS LLC14 citations93

US9968613B2May 15, 2018

Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb

VTV THERAPEUTICS LLC12 citations92

US9487493B2Nov 8, 2016

Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator

VTV THERAPEUTICS LLC6 citations84

US9855274B2Jan 2, 2018

Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists

VTV THERAPEUTICS LLC7 citations84

US9855251B2Jan 2, 2018

Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator

VTV THERAPEUTICS LLC7 citations84

US9663481B2May 30, 2017

Phenoxy acetic acids and phenyl propionic acids as PPARδ agonists

VTV THERAPEUTICS LLC7 citations84

US9393245B2Jul 19, 2016

Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors

VTV THERAPEUTICS LLC7 citations84

US10456406B2Oct 29, 2019

Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb

VTV THERAPEUTICS LLC9 citations83

US10952993B2Mar 23, 2021

Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs

VTV THERAPEUTICS LLC5 citations82

US10980861B2Apr 20, 2021

Glucokinase activator compositions for the treatment of diabetes

VTV THERAPEUTICS LLC4 citations81

US10947180B2Mar 16, 2021

Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists

VTV THERAPEUTICS LLC4 citations81

US10588943B2Mar 17, 2020

Glucokinase activator compositions for the treatment of diabetes

VTV THERAPEUTICS LLC5 citations81

US10004782B2Jun 26, 2018

Glucokinase activator compositions for the treatment of diabetes

VTV THERAPEUTICS LLC10 citations81

US10568888B2Feb 25, 2020

Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors

VTV THERAPEUTICS LLC2 citations73

US10391097B2Aug 27, 2019

Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors

VTV THERAPEUTICS LLC2 citations73

US11649230B2May 16, 2023

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

VTV THERAPEUTICS LLC1 citations72

US11130753B2Sep 28, 2021

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

VTV THERAPEUTICS LLC2 citations72

US11096946B2Aug 24, 2021

Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb

VTV THERAPEUTICS LLC2 citations72

US10898475B2Jan 26, 2021

Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereof

VTV THERAPEUTICS LLC2 citations72

US10889580B2Jan 12, 2021

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

VTV THERAPEUTICS LLC2 citations72

US10570126B2Feb 25, 2020

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

VTV THERAPEUTICS LLC2 citations72

US10463652B2Nov 5, 2019

Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereof

VTV THERAPEUTICS LLC4 citations72

US10172840B2Jan 8, 2019

Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereof

VTV THERAPEUTICS LLC4 citations72

US10030011B2Jul 24, 2018

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

VTV THERAPEUTICS LLC2 citations72

US9707239B2Jul 18, 2017

Compounds that modulate oxidative stress

VTV THERAPEUTICS LLC3 citations72

US9447468B2Sep 20, 2016

Compounds that modulate oxidative stress

VTV THERAPEUTICS LLC5 citations72

US11974989B2May 7, 2024

Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs

VTV THERAPEUTICS LLC1 citations71

US11833136B2Dec 5, 2023

Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs

VTV THERAPEUTICS LLC1 citations71

US11524942B2Dec 13, 2022

Metabolites of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4 yl}-phenoxy)-propyl]-diethyl-amine

VTV THERAPEUTICS LLC2 citations71

US10363241B2Jul 30, 2019

Substituted imidazole derivatives and methods of use thereof

VTV THERAPEUTICS LLC1 citations71

US9717710B2Aug 1, 2017

Treatment of mild and moderate Alzheimer's disease

VTV THERAPEUTICS LLC5 citations68

US11420929B2Aug 23, 2022

Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists

VTV THERAPEUTICS LLC0 citations62

US10085990B2Oct 2, 2018

Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors

VTV THERAPEUTICS LLC1 citations62

US9833457B2Dec 5, 2017

Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors

VTV THERAPEUTICS LLC1 citations62

US9687489B2Jun 27, 2017

Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors

VTV THERAPEUTICS LLC1 citations62

US12391658B2Aug 19, 2025

Sulfoxide and sulfone glucokinase activators and methods of use thereof

VTV THERAPEUTICS LLC1 citations60

US11970457B2Apr 30, 2024

Metabolites of [3-(4-(2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl)-phenoxy)-propyl]-diethyl-amine

VTV THERAPEUTICS LLC0 citations60

US11420942B2Aug 23, 2022

Crystalline forms of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine

VTV THERAPEUTICS LLC2 citations59

US12545676B2Feb 10, 2026

Crystalline form of hydrochloride salt of quinoline derivative

VTV THERAPEUTICS LLC0 citations51

US12091407B2Sep 17, 2024

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

VTV THERAPEUTICS LLC0 citations51

US10364233B2Jul 30, 2019

Piperidine derivative and methods of use thereof

VTV THERAPEUTICS LLC0 citations50

US9598375B2Mar 21, 2017

Substituted imidazole derivatives and methods of use thereof

VTV THERAPEUTICS LLC0 citations50

US11883383B2Jan 30, 2024

Pharmaceutically acceptable salts of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine

VTV THERAPEUTICS LLC0 citations48

US12479808B2Nov 25, 2025

Salts or co-crystals of {2-[3-cyclohexyl-3-(trans-4-propoxy-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl}-acetic acid and uses thereof

VTV THERAPEUTICS LLC0 citations39

VTV THERAPEUTICS LLC

Top patents by PatentIndex Score

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb

Use of a PPAR-delta agonist for treating muscle atrophy

Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists

Compositions comprising metformin and a glucokinase activator

Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator

Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists

Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator

Phenoxy acetic acids and phenyl propionic acids as PPARδ agonists

Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors

Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb

Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs

Glucokinase activator compositions for the treatment of diabetes

Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists

Glucokinase activator compositions for the treatment of diabetes

Glucokinase activator compositions for the treatment of diabetes

Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors

Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb

Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereof

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereof

Bach1 inhibitors in combination with Nrf2 activators and pharmaceutical compositions thereof

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

Compounds that modulate oxidative stress

Compounds that modulate oxidative stress

Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs

Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs

Metabolites of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4 yl}-phenoxy)-propyl]-diethyl-amine

Substituted imidazole derivatives and methods of use thereof

Treatment of mild and moderate Alzheimer&#39;s disease

Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists

Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors

Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors

Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors

Sulfoxide and sulfone glucokinase activators and methods of use thereof

Metabolites of [3-(4-(2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl)-phenoxy)-propyl]-diethyl-amine

Crystalline forms of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine

Crystalline form of hydrochloride salt of quinoline derivative

Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

Piperidine derivative and methods of use thereof

Substituted imidazole derivatives and methods of use thereof

Pharmaceutically acceptable salts of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine

Salts or co-crystals of {2-[3-cyclohexyl-3-(trans-4-propoxy-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl}-acetic acid and uses thereof

Treatment of mild and moderate Alzheimer's disease